Pathogenesis of respiratory syncytial virus vaccine-augmented pathology (Q40408366)

20 September 2017

1 reference

title

Pathogenesis of respiratory syncytial virus vaccine-augmented pathology (English)

1 reference

20 September 2017

Graham BS

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

American Journal of Respiratory and Critical Care Medicine

20 September 2017

published in

1 reference

20 September 2017

volume

152

1 reference

20 September 2017

issue

4 Pt 2

1 reference

20 September 2017

page(s)

S63-6

1 reference

Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Monoclonal antibodies protect against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Altered reactivity to measles virus. Skin test reactivity and antibody response to measles virus antigens in recipients of killed measles virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Distinct types of lung disease caused by functional subsets of antiviral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

A Role for CD4+T-Cell Subsets Producing a Selective Pattern of Lymphokines in the Pathogenesis of Human Chronic Inflammatory and Allergic Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F152.4_PT_2.S63

10.1164/AJRCCM/152.4_PT_2.S63

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference